ErratumErratum to ‘Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma’ [Eur J Cancer 108 (February 2019) 33–40]
Cited by (0)
© 2019 Published by Elsevier Ltd.